#SocPharm Tweetchat Transcript 9/29/2010

EileenOBrien:
Good morning & welcome to the quarterly morning edition of #socpharm. Plse introduce yourself & say why you are interested in this topic.

EileenOBrien:
I’m Eileen, work for Siren where we focus on relationship marketing for #rarediseases & love all things interwebs #socpharm

EileenOBrien:
@bradatpharma Good morning Brad, that’s a good topic: how do companies develop best practices around sm? #socpharm

Armor_Graphics:
RT @EileenOBrien: Good morning & welcome to quarterly edition of #socpharm. Plse intro. yourself & say why your interested in topic. #DelBio

impactiviti:
I’m Steve Woodruff and I’m the eHarmony of pharma training and marketing. #socpharm

EileenOBrien:
What a gr8 description of what you do! RT @impactiviti: I’m Steve Woodruff and I’m the eHarmony of pharma training and marketing. #socpharm

jaysbryant:
Hi everyone in #socpharm – I work at @liveworld & provide SM platforms, community management & content moderation services to pharma cos

EileenOBrien:
T1: How have you seen companies develop best practices around sm, which is new/evolving? #socpharm

EileenOBrien:
I apologize in advance #socpharm tweeps that I’m a bit distracted because I’m at #epatcon which is just starting.

EileenOBrien:
Is it easier if you get an outside consultant to come in & help lead a team to develop best practices? #socpharm

askmanny:
#socpharm tweeps: @EileenOBrien is ours today! ~ Signed: a happy #epatcon attendee.

bradatpharma:
T1: i still think you’ve got to have a few people who know what to ask the agencies. Otherwise you’re at a major disadvantage. #socpharm

impactiviti:
I would think that an outside consultant can help at least create the basic framework. But no company should try to… #socpharm

impactiviti:
…short-circuit the process of creating something very specific that reflects company culture and policy (and goals!) #socpharm

bradatpharma:
Now I’m being distracted by our meeting. Since I’m being paid to be here & in the front row I need to at least pretend to focus #socpharm

EileenOBrien:
@bradatpharma Absolutely. Can the desire for development of best practices come from the bottom or does it need to be top down? #socpharm

ddwebster:
Good morning! joining #socpharm for 1st time in months. Dana Webster, SM Specialist @ ParaPRO (Pharma co) & former field rep

ddwebster:
consultants can be helpful to teach tools, SM core philosophies-I believe co. has to create policy based upon their core values #socpharm

EileenOBrien:
T2: In keeping w/ePatient theme, check out @susannahfox‘s blog abt retiring the term epatienthttp://bit.ly/bcovmo Agree? #socpharm

EileenOBrien:
@bradatpharma No worries, tx for joining in briefly. Twitter search is SO slow this morning, our chat isn’t very dynamic! #socpharm

impactiviti:
@EileenOBrien @bradatpharma I suspect it can be spurred from the bottom, but ultimately has to be driven to final form from top. #socpharm

EileenOBrien:
I just checked Twitter status and it’s down!! #socpharm

JaeSelle:
yes. accept there is no dif RT @EileenOBrien check out @susannahfox‘s blog a/b retiring term epatient http://bit.ly/bcovmo Agree? #socpharm

EileenOBrien:
The Twitter status update itself is down I mean #socpharm

pharmaguapa:
hello #socpharm I’m an independent consultant in digi pharma based in EU – will only be popping in & out as multitasking today

impactiviti:
@bradatpharma Maureen Byrne from some company called Novartis now speaking at ePatient Conference…! #socpharm

ddwebster:
@EileenOBrien re @bradatpharma I personally believe the bottom dwellers should help shape BP’s bcuz of more direct cust. contac #socpharm

pharmaguapa:
An outside consultant can be useful in providing an outside view and objectivity but core needs to be done internally #socpharm

EileenOBrien:
T2: Yesterday @rarediseases on Facebook asked abt epatient term: “When dr has to google your disease have to be empowered patient” #socpharm

ddwebster:
T2: I have no problem w/e-pat term. Too many patients are apathetic, I think e-patient is a positive designation. I am an e-pat #socpharm

SpitzStrategy:
Very smart! RT @jonmrich: “Social Sharing Tools in Pharma and Healthcare ? A New Solution”http://t.co/b4i0DAI #fdasm #socpharm

EileenOBrien:
T3: What do you think of Novartis doing a CF video about a patient experience but using an actor? Openly disclosed. #socpharm

EileenOBrien:
Sorry everyone, gave up on #socpharm due to Twitter issues. See you next Wed at usual time 8 pm EST.